Email updates

Keep up to date with the latest news and content from Virology Journal and BioMed Central.

Open Access Highly Accessed Short report

The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus

Kelsey A Haugh, Natalia Shalginskikh, Shoko Nogusa, Anna Marie Skalka, Richard A Katz* and Siddharth Balachandran*

Author Affiliations

Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Room 422 Reimann Building, 333 Cottman Ave., 19111 Philadelphia, PA, USA

For all author emails, please log on.

Virology Journal 2014, 11:100  doi:10.1186/1743-422X-11-100

Published: 28 May 2014

Abstract

Background

The antiviral protein Daxx acts as a restriction factor of avian sarcoma virus (ASV; Retroviridae) in mammalian cells by promoting epigenetic silencing of integrated proviral DNA. Although Daxx is encoded by a type I (α/β) interferon-stimulated gene, the requirement for Daxx in the interferon anti-retroviral response has not been elucidated. In this report, we describe the results of experiments designed to investigate the role of Daxx in the type I interferon-induced anti-ASV response.

Findings

Using an ASV reporter system, we show that type I interferons are potent inhibitors of ASV replication. We demonstrate that, while Daxx is necessary to silence ASV gene expression in the absence of interferons, type I interferons are fully-capable of inducing an antiviral state in the absence of Daxx.

Conclusions

These results provide evidence that Daxx is not essential for the anti-ASV interferon response in mammalian cells, and that interferons deploy multiple, redundant antiviral mechanisms to protect cells from ASV.

Keywords:
Daxx; Interferon; Avian sarcoma virus; Innate immunity